Table 1 Baseline clinical characteristic of patients with and without CIN
Variable | CIN (+) n = 31 | CIN (−) n = 115 | P value |
|---|---|---|---|
Women | 9 (29) | 22 (19.1) | 0.232* |
Age (years) | 57.1 ± 14.2 | 56.4 ± 12.0 | 0.770 |
BMI (kg/m2) | 24.5 ± 4.6 | 24.5 ± 3.7 | 0.975 |
Smoking, n (%) | 12 (38.7) | 34 (29.6) | 0.331 |
Hypertension, n (%) | 12 (38.7) | 58 (50.4) | 0.246* |
Diabetes mellitus, n (%) | 7 (22.6) | 38 (33.0) | 0.263* |
Hyperlipidaemia, n (%) | 19 (61.3) | 55 (47.8) | 0.183* |
Hyperuricemia, n (%) | 12 (38.7) | 21 (18.3) | 0.016* |
CKD, n (%) | 8 (25.8) | 10 (8.7) | 0.010* |
Pre-procedure SCr (μmol/L) | 98.7 ± 39.8 | 86.0 ± 37.7 | 0.101 |
Pre-procedure eGFR (ml/min/1.73m2) | 81.3 ± 32.6 | 93.1 ± 27.5 | 0.045 |
< 30 n (%) | 2 (6.5) | 2 (1.7) | |
≥30, < 60 n (%) | 6 (19.4) | 9 (7.8) | |
≥60 n (%) | 23 (74.2) | 104 (90.4) | |
CHF n (%) | 5 (16.1) | 24 (20.9) | 0.557* |
Hypotension, n (%) | 0 (0) | 6 (5.2) | 0.194* |
LVEF(%) | 50.0 ± 9.0 | 53.9 ± 10.0 | 0.053 |
Diagnosis, n (%) | 0.615* | ||
UA | 5 (16.1) | 26 (22.6) | |
NSTEMI | 10 (32.3) | 40 (34.8) | |
STEMI | 16 (51.6) | 49 (42.6) | |
Diseased vessels | 2.0 ± 1.0 | 2.1 ± 0.8 | 0.492 |
MVD, n (%) | 12 (38.7) | 44 (38.3) | 0.964* |
LAD target vessel, n (%) | 18 (58.1) | 45 (39.1) | 0.059* |
Contrast volume (mL) | 124 ± 43 | 121 ± 32 | 0.686 |
Contrast volume/kg (mL/kg) | 1.9 ± 0.8 | 1.8 ± 0.6 | 0.650 |
24 h hydration volume (mL) | 2180 ± 681 | 1868 ± 701 | 0.029 |
Haemoglobin (g/L) | 135.1 ± 20.7 | 132.7 ± 19.4 | 0.548 |
Homocysteinemia (μmol/L) | 17.3 ± 4.8 | 13.3 ± 3.7 | 0.000 |
SBP pre-procedure (mmHg) | 133 ± 16.5 | 126 ± 21.6 | 0.116 |
DBP pre-procedure (mmHg) | 81.3 ± 11.7 | 80.0 ± 15.4 | 0.671 |